Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Clinico-Pathological Significance of MHC-I Type Chain-associated Protein A Expression in Oral Squamous Cell Carcinoma

  • Wang, Jie (Department of Immunology, Xiangya Medical School, Central South University) ;
  • Li, Chao (Department of Oral and Maxillofacial Surgery, Xiang Ya Hospital, Central South University) ;
  • Yang, Dan (Department of Oral and Maxillofacial Surgery, Xiang Ya Hospital, Central South University) ;
  • Jian, Xin-Chun (Department of Oral and Maxillofacial Surgery, Xiang Ya Hospital, Central South University) ;
  • Jiang, Can-Hua (Department of Oral and Maxillofacial Surgery, Xiang Ya Hospital, Central South University)
  • Published : 2012.02.29
Download PDF
⟨ Previous Next ⟩

Abstract

The current research concerns the clinicopathological significance of MHC class I chain-related protein A (MICA) expression in oral squamous cell carcinomas (OSCCs). The expression and location of MICA protein in 14 normal oral mucous and 45 cancerous and para-cancerous tissues were assessed by immunohistochemistry and levels of MICA mRNA expression in 29 cancerous and para-cancerous tissues were determined by the real-time polymerase chain reaction. Data were analyzed with the SPSS16.0 software package. MICA was found to be located in the cytoplasm and plasma membrane. Expression was higher in para-cancerous than in cancerous tissues (P < 0.05). However, no statistical difference was found between the following: 1) para-cancerous tissue with normal mucosa; 2) normal mucosa with cancerous tissue;and 3) among different clinicopathological parameters in OSCC (P > 0.05). The level of MICA mRNA was higher in OSCCs than in para-cancerous tissues, and was correlated with the regional lymph node status and disease stage (P < 0.05). The levels of MICA protein and mRNA expression differ among normal oral mucosa, para-cancerous tissue, and cancerous tissue. MICA may contribute to the tumorigenesis and progression of OSCC.

Keywords

References

  1. Bauer S, Groh V, Wu J, et al (1999). Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science, 285, 727-9. https://doi.org/10.1126/science.285.5428.727
  2. Diefenbach A, Jensen ER, Jamieson AM, et al (2001). Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature, 413, 1652-71.
  3. Fuertes MB, Girart MV, Molinero LL, et al (2008). Intracellular Retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity. J Immunol. 180, 4606-14. https://doi.org/10.4049/jimmunol.180.7.4606
  4. Jinushi M, Takehara T, Tatsumi T, et al (2003). Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int J Cancer, 104, 354-61. https://doi.org/10.1002/ijc.10966
  5. Kaiser BK, Yim D, Chow IT, et al (2007). Disulphide-isomeraseenabled shedding of tumour-associated NKG2D ligands. Nature, 447, 482-6. https://doi.org/10.1038/nature05768
  6. Li P, Morris DL, Willcox BE, et al (2001). Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol, 2, 443-51. https://doi.org/10.1038/87757
  7. Liu CJ, Lui MT, Chen HL, et al (2007). MICA and MICB overexpression in oral squamous cell carcinoma. J Oral Pathol Med, 36, 43-7.
  8. Madjd Z, Spendlove I, Moss R, et al (2007). Upregulation of MICA on high-grade invasive operable breast carcinoma. Cancer Immun, 7, 17.
  9. Ostberg JR, Dayanc BE, Yuan M, et al (2007). Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. J Leukoc Biol, 82, 1322-31. https://doi.org/10.1189/jlb.1106699
  10. Sutherland CL, Chalupny NJ, Schooley K, et al (2002). UL16- binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J Immunol, 168, 671-9. https://doi.org/10.4049/jimmunol.168.2.671
  11. Tamaki S, Sanefuzi N, Kawakami M, et al (2008). Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients. Hum Immunol, 69, 88-93. https://doi.org/10.1016/j.humimm.2008.01.010
  12. Waldhauer I, Goehlsdorf D, Gieseke F, et al (2008). Tumorassociated MICA is shed by ADAM proteases. Cancer Res, 68, 6368-76. https://doi.org/10.1158/0008-5472.CAN-07-6768
  13. Wu J, Song Y, Bakker AB, et al (1999). An activating immunoreceptor complex formed by NKG2D and DAP10. Science, 285, 730-2. https://doi.org/10.1126/science.285.5428.730
  14. Xiao P, Xue L, Che LH, et al (2008). Expression and roles of MICA in human osteosarcoma. Histopathology, 52, 640-2. https://doi.org/10.1111/j.1365-2559.2008.02989.x
  15. Zhang C, Niu J, Zhang J, et al (2008). Opposing effects of interferon-alpha and interferon-gamma on the expression of major histocompatibility complex class I chain-related A in tumors. Cancer Sci, 99, 1279-86. https://doi.org/10.1111/j.1349-7006.2008.00791.x

Cited by

  1. Clinical Significance of Soluble Major Histocompatibility Complex Class I Chain-related A in Renal Cell Carcinoma Patients vol.14, pp.10, 2013, https://doi.org/10.7314/APJCP.2013.14.10.5651
  2. Cell motility and spreading promoted by CEACAM6 through cyclin D1/CDK4 in human pancreatic carcinoma vol.35, pp.1, 2015, https://doi.org/10.3892/or.2015.4338